key: cord-0019604-0oz11wt0
authors: McMenamin, Alexander J.; Parekh, Fenali; Lawrence, Verena; Flenniken, Michelle L.
title: Investigating Virus–Host Interactions in Cultured Primary Honey Bee Cells
date: 2021-07-17
journal: Insects
DOI: 10.3390/insects12070653
sha: 8cdd415416b803b6d927dc17d7c3346685eba023
doc_id: 19604
cord_uid: 0oz11wt0

SIMPLE SUMMARY: Honey bees are eusocial insects that live in colonies comprised of ~30,000 individuals. They are the primary pollinators of plants that produce fruits, nuts, and vegetables. High annual losses of honey bee colonies have made it challenging for beekeepers to provide enough colonies to meet the demand for pollination services. Multiple stressors, including viruses, contribute to colony deaths. To better understand viral pathogenesis and bee antiviral defense mechanisms, we obtained primary cells from honey bee larvae and pupae, maintained them in culture, and infected them with a panel of viruses. We determined that larval hemocytes, which are primary immune cells, support replication of a honey bee virus (sacbrood virus) and a model virus (Flock House virus). Similarly, we determined that mixed cell populations derived from honey bee pupae support replication of sacbrood virus, Flock House virus, and another honey bee virus (deformed wing virus). Evaluation of the host cellular level response to infections with each of these viruses revealed unique expression profiles of three immune genes. In summary, this study demonstrates the utility of honey bee primary cell cultures to investigate the impacts of virus infection on honey bees at the cellular level, which in turn affects individual bee and colony health. ABSTRACT: Honey bee (Apis mellifera) health is impacted by viral infections at the colony, individual bee, and cellular levels. To investigate honey bee antiviral defense mechanisms at the cellular level we further developed the use of cultured primary cells, derived from either larvae or pupae, and demonstrated that these cells could be infected with a panel of viruses, including common honey bee infecting viruses (i.e., sacbrood virus (SBV) and deformed wing virus (DWV)) and an insect model virus, Flock House virus (FHV). Virus abundances were quantified over the course of infection. The production of infectious virions in cultured honey bee pupal cells was demonstrated by determining that naïve cells became infected after the transfer of deformed wing virus or Flock House virus from infected cell cultures. Initial characterization of the honey bee antiviral immune responses at the cellular level indicated that there were virus-specific responses, which included increased expression of bee antiviral protein-1 (GenBank: MF116383) in SBV-infected pupal cells and increased expression of argonaute-2 and dicer-like in FHV-infected hemocytes and pupal cells. Additional studies are required to further elucidate virus-specific honey bee antiviral defense mechanisms. The continued use of cultured primary honey bee cells for studies that involve multiple viruses will address this knowledge gap.

All organisms are infected by viruses, which are obligate intracellular pathogens that rely on host cell machinery to replicate. In turn, hosts evolve mechanisms to prevent and/or the development of immortalized honey bee cell lines, AmE-711 has a long doubling time, is difficult to maintain in other labs, and it is persistently infected with DWV [10] . Therefore, the use of non-honey-bee cells lines, including the Lepidopteran hemocytic cell line (P1), to study honey-bee-infecting viruses, including DWV, have been explored and will likely serve as an important tool for investigating bee viruses at a cellular level [8, 151] . While immortalized cell cultures provide a convenient and consistent tool, they often do not fully recapitulate in situ biology. For example, the immune response that AmE-711, a honey bee fibroblast-type cell line, mounts against viruses may not represent the immune response in other honey bee tissues or cell types (i.e., fat body, endothelium, or hemocytes).

Primary honey bee cell cultures derived from different tissues provide a useful alternative to immortalized cell lines for the study of basic honey bee virology and immunology (reviewed in [152] ). There are several advantages and disadvantages associated with the use of either immortalized cell lines or primary cells. For example, primary cultures may harbor preexisting infections, while immortalized cells may be persistently infected; therefore, it is best to carry out pathogen testing to ensure that the results obtained are not impacted by other infections [153] [154] [155] [156] [157] [158] [159] [160] . Beneficial features of tissue-derived primary cell cultures include that they can contain diverse cell types or be enriched for one cell type. In addition, they can be generated from pooled tissue samples to control for the inter-individual variability associated with whole-animal experiments. Primary cell cultures that represent multiple individuals may be particularly important for generating robust data that is representative of outbred honey bee colonies comprising individuals from numerous unique patrilines. Primary cell cultures established from whole pupae, with differentiated head, thorax, and abdomen body segments, likely include numerous adipocytes and epithelial cells as well as more specialized cells including neurons and muscle cells. These mixed cell cultures may be beneficial for investigating virus-tropism and intercellular signaling in response to virus infection. Similarly, the establishment and use of primary cell cultures from specific tissues or cell types facilitates a more precise mechanistic-level understanding of host-virus interactions [3, 161, 162] . Hemocytes are the primary insect immune cells that phagocytose or encapsulate pathogens. There are several subtypes of hemocytes, which are characterized morphologically, histochemically, and/or functionally. These include prohemocytes, granulocytes, plasmatocytes, spherulocytes, and oenocytoids, which may be further distinguished based on functional diversity [163] . Honey bee hemocytes also exhibit functional and morphological heterogeneity. The majority of circulating phagocytic cells in bee larvae are granulocytes, whereas plasmatocytes are more prevalent in adults [164, 165] . There may be additional infection-induced cell types not yet described, like lamellocytes in Drosophila melanogaster, which are induced upon infestation by a parasitoid wasp [166] . In addition to their heterogeneity in phagocytic ability, honey bee hemocytes differ in their expression of hemolectin, which is associated with an encapsulation response of foreign bodies [167] . While recent studies in Drosophila melanogaster demonstrate that hemocytes play a role in systemic antiviral immune response, the potential for hemocytes to be infected by viruses or the extent to which they may contribute to honey bee antiviral immunity is not known [96, 163, [168] [169] [170] [171] .

To investigate honey bee antiviral defense mechanisms at the cellular level, we further developed the use of cultured primary cells, derived from either larvae or pupae, and demonstrated that these cells could be infected with a panel of viruses, including common honey bee infecting viruses (i.e., SBV and DWV) and a model virus (FHV). Specifically, hemocytes obtained from stage L4-L5 honey bee larvae supported infection and replication of SBV and FHV. Virus replication was verified via detection of the replicative intermediate of both viruses using negative-strand-specific reverse transcription (RT), followed by polymerase chain reaction (PCR), and using quantitative PCR (qPCR) to demonstrate increased virus abundance over an infection time course. Mixed cell populations derived from purple-eyed honey bee pupae supported replication of SBV, DWV, and FHV. Virus replication was verified via negative-strand-specific RT-PCR and qPCR. Peak virus abundance was observed at 96 h post-infection (hpi) for SBV and DWV, while virus abundance peaked at 72 hpi for FHV. Furthermore, the production of infectious virions in cultured honey bee pupal cells was demonstrated by determining that naïve cells became infected after the transfer DWV or FHV infected cell culture material. Initial characterization of the honey bee antiviral immune responses mounted against SBV, DWV, and FHV at the cellular level indicate varying virus-specific responses, including increased expression of bee antiviral protein-1 (GenBank: MF116383) in SBV-infected pupal cells and increased expression of argonaute-2 and dicer-like in FHV-infected hemocytes and pupal cells [107, 172] . Additional studies utilizing primary honey bee cell cultures and multiple viruses will help elucidate virus-specific antiviral defense mechanisms.

Packages (~1.5 kg of worker bees and a mated queen) of Carniolan honey bees (Apis mellifera carnica) were purchased from a commercial producer in Montana and installed in Langstroth hives at Montana State University, Bozeman, MT, USA. Colonies were maintained using standard apicultural practices, including bi-monthly Varroa destructor mite checks by the sugar roll method and treatment for mites with Mite Away Quick Strips (Nature's Own Design Apiary Products, Frankford, ON, Canada) when mite infestation was evaluated to be greater than 3% (3 mites per 100 bees [173, 174] ).

Three days before experiments using primary honey bee hemocytes were performed, frames of brood with a lot of 4th and 5th instar larvae (L4-L5) were brought to the laboratory and maintained in a humidified incubator at 28 • C. Larvae that fell out of their cells were caught in a glass dish and collected in batch the next morning. After collection, larvae were surface-sterilized for 3 min in 0.6% hypochlorite (dilute bleach), followed by 3 min in 70% ethanol, and then briefly washed in sterile water for injection (Gibco) in a biological safety cabinet (Class II type A/B3, Nuaire). Larvae were placed into 200 µL of WH2 media (pH 6.4, 150 mL Schneider's insect medium, SIGMA cat# S0146; 200 mL 0.06M L-Histidine, SIGMA cat# H5659; 50 mL heat-inactivated fetal bovine serum, Life Technologies cat# 16000044; 15 mL CMRL medium, Gibco cat# 11530-037; 5 mL Hank's balanced salts, SIGMA cat# H9394; 2 mL insect media supplement, SIGMA cat# I7267), supplemented with 1× penicillin/streptomycin (ThermoFisher, cat# 15070063), 10 at a time [33, 175] . Sterile 18guage needles were used to wound larvae on the lateral cuticle of the abdomen. Each larva was wounded once on each side and exsanguinated directly into the media. Care was taken to minimize fat body release from the carcass to produce cultures with minimal adipocyte contamination (Supplemental Figure S1 ). Hemocytes were pooled in 15 mL conical tubes (Falcon, Corning) until enough were collected for each experiment. Hemocytes were then seeded in vacuum gas plasma treated polystyrene 48-well plates (Falcon, Corning). On average, six larvae provided enough hemocytes (~1 × 10 5 cells per well) for five wells on a 48-well plate.

To test for virus association with carcasses versus hemocytes, an independent set of larvae was obtained from two different colonies, and sterile 18-guage needles were used to wound individual larva (n = 37) on the lateral cuticle of the abdomen. Each larva was wounded one on each side and exsanguinated. Hemolymph was directly collected by pipetting (approximately 40 µL). Hemolymph was diluted with 100 µL WH2 media; then, hemocytes were pelleted by centrifuging at 1000× g for 10 min. Supernatant was removed, and hemocytes were suspended in 100 µL WH2 media. Then, 800 µL of TRIzol ® reagent (Invitrogen) was added to the hemocytes, and they were stored at −80 • C until RNA extraction. 

Two days prior to honey bee pupal cell experiments, a brood frame containing purpleeyed pupae was brought into the lab. Fine-point, curved-tip forceps (Bioquip) were used to carefully remove the wax capping from pupae. Wide-tip, featherweight forceps (Bioquip) were used to gently grasp pupae between the eyes to remove them from the wax comb cells in which they develop. Pupae were incubated at 28 • C overnight in 12-well plates, and wounded (i.e., melanized) pupae were discarded. Primary cells were harvested from surface-sterilized honey bee pupae in a biosafety cabinet (Class II type A/B3, Nuaire). Surface sterilization was carried out in a sterile polystyrene petri dish (100 mm × 15 mm, Fisher), in which pupae were swirled in 0.6% hypochlorite solution (diluted bleach) for 3 min, 70% ethanol for 3 min, and briefly in sterile water for injection (Gibco). In groups of two, pupae were dissected into head, thorax, and abdomen segments in 2 mL WH2 medium in a 47 mm dish using sterile 18-gauge needles to vigorously disturb tissues and release cells into the medium [175] . The media containing the cells was then transferred to a 50 mL conical tube, and cells from individual pupa (~24 × 10 6 cells) were pooled. Cell suspensions with approximately 10 6 cells per 300 µL were plated into each well of a 48-well plate and incubated at room temperature overnight before infection.

A stock of sacbrood virus was prepared from five symptomatic larvae, which were homogenized in 10 mM Tris (pH 7.5) using a sterile steel ball (5 mm) in a 2 mL microcentrifuge tube, using a Tissue Lyser II (Qiagen) at 30 Hz for 2 min. Cell debris was pelleted by centrifugation at 10,000× g for 10 min at 4 • C, and the clarified lysate was sequentially filtered through a 0.45 µm filter and then a 0.2 µm filter to remove small debris and microbes. To characterize this virus preparation, RNA was isolated from 100 µL using TRIzol ® reagent (as described below), and cDNA template was used for pathogen-specific PCR and qPCR. PCR confirmed the presence of SBV and the absence of other common honey bee viruses, including ABPV, BQCV, CBPV, DWV, IAPV, KBV, and LSVs (Supplemental Figure S11 ). Quantitative PCR was used to determine the relative abundance of SBV, using SBV RNA copy number as a proxy for virus abundance, while recognizing that in this crude virus preparation, RNA copies may represent both RNA genomes and transcripts. The SBV inoculum contained 5900 copies/ng RNA. Each well of a 48-well plate was inoculated with 2.5 × 10 6 SBV RNA copies.

DWV inoculum was prepared according to standard methods [176] . In brief, whiteeyed pupae were carefully removed from the brood comb and collected into a petri dish lined with filter paper dampened with sterile water. Microcapillary glass needles for injections were made by pulling borosilicate glass capillary tubes (100 mm long, 1 mL capacity, Kimble-Chase) with a coil temperature of 61 • C on the PC-10 Dual-Stage Glass Micropipette Puller (Narishige). Pupae were injected with DWV (3.41 × 10 7 DWV RNA copies in 2 µL) between the 2nd and 3rd integuments of the abdomen using the borosilicate glass needle and a Harbo syringe (Honey bee Insemination Service). Pupae were incubated at 30 • C in a humid incubator over the course of infection and examined daily to ensure they were alive. Live pupae were harvested at 10 days post-injection, and individual pupae were homogenized in 1 mL PBS (pH 7.4) using a sterile steel ball (5 mm) and Tissue Lyser II (Qiagen) at 30 Hz for 2 min. Cell debris was pelleted by centrifugation at 10,000× g for 10 min at 4 • C. To characterize this virus preparation, RNA was isolated from 100 µL using TRIzol ® reagent (Invitrogen) (as described below), and cDNA template was used for pathogen-specific PCR and qPCR. PCR confirmed the presence of DWV and the absence of other common honey bee viruses, including ABPV, BQCV, CBPV, IAPV, KBV, LSVs, and SBV (Supplemental Figure S12 ). Quantitative PCR was used to determine the relative abundance of DWV, using virus RNA copy number as a proxy for virus abundance, while FHV was propagated in Drosophila melanogaster Schneider 2 (S2) cells (Invitrogen), an immortalized cell line originally derived from D. melanogaster embryos. S2 cells were grown in Schneider's Drosophila medium supplemented with 10% heat-inactivated fetal bovine serum (Life Technologies) and 1% penicillin-streptomycin. A sterile T75 flask was seeded with 4 × 10 7 S2 cells/mL and infected with FHV at a multiplicity of infection of 1 pfu/cell, as provided by Dr. Anette Schneemann (The Scripps Research Institute, La Jolla, CA, USA). The virus stock was quantified via plaque assay by the Schneemann lab using previously described protocols [177] . The S2 cells infected using this aliquot were incubated at 28 • C for 48 h, lysed by addition of 10% (v/v) Nonidet P-40, and incubated on ice for 10 min with periodic swirling [178] . Cell debris was pelleted at 13,800× g for 10 min at 4 • C, and the clarified supernatant was transferred to a fresh tube. Using an ultracentrifuge (Beckman Coulter), virus was pelleted through 1 mL volume of 30% (wt/wt) sucrose in 50 mM HEPES (pH 7) at 40,000 rpm for 2.5 h at 11 • C in a SW41 Ti swinging-bucket rotor. The resulting pellets were resuspended in 0.5 mL buffer (HEPES 50 mM, pH 7), and any remaining insoluble material was removed by centrifugation at 10,000 rpm for 10 min. The clarified supernatant was layered on a continuous sucrose gradient (40%, 35%, 30%, 25%, 20%, 15%, and 10% (wt/wt)) and centrifuged at 40,000 rpm for 1.5 h at 11 • C to sediment the virus between 25-35% sucrose gradients. RNA was isolated from 100 µL virus preparations (as described below), and FHV abundance was quantified by qPCR, with the copy number based on a standard curve. For the infection experiments described herein, hemocytes were infected with 1 × 10 6 FHV RNA copies, and pupal cells were infected with 2 × 10 8 FHV RNA copies. FHV infection experiments were monitored over a time course from 0 h to 96 h post-infection.

Small amounts of virus-infected cell culture, including cells and culture supernatant, from initial infections were transferred to naïve pupal cells, seeded in 48-well plates as described above. Primary purple-eyed honey bee pupal cells were seeded at approximately 10 6 cells per 300 µL media and incubated at room temperature overnight before infection. Each well was infected with 10 µL of mock-or virus-infected pupal cell culture. The resulting infected cells were incubated at room temperature for 0 h, 48 h, and 72 h post-infection.

RNA was isolated from cultured adherent hemocytes or non-adherent pupal cells/cell culture media at indicated time points using TRIzol ® reagent (Invitrogen) according to manufacturer's instructions. In brief, cell culture medium from each well (300 µL) was collected into a microcentrifuge tube. Then, 300 µL of TRIzol ® reagent (Invitrogen) was added to each well, incubated for 1 min, and then combined with the corresponding cell culture media sample. Samples were stored at −80 • C until RNA extraction. To complete RNA isolation, an additional 450 µL of TRIzol was added to each sample, which was vortexed and incubated at room temperature for 5 min. Then, 160 µL of chloroform was added, and samples were shaken by hand (15 s) and incubated at room temperature (2 min). Samples were centrifuged at 12,000× g for 15 min, and the aqueous phase was transferred to a clean microcentrifuge tube. An equal volume of isopropanol (~550 µL) and 20 µg of glycogen (Thermo Scientific) were added to the aqueous phase, which was then mixed by inverting. RNA was precipitated after overnight incubation (~18 h) at −20 • C by centrifugation at 4 • C for 15 min at 14,000× g. Supernatants were carefully removed by pipetting, and each pellet was washed twice with 75% ethanol. Final pellets were air-dried at room temperature until visually dry (~20 min). The pellet was suspended in 30 µL nuclease-free water; then, 3 µL 3M sodium acetate (pH 5.5) and 120 µL ethanol were added, and RNA was precipitated overnight at −20 • C. Next, samples were centrifuged at 14,000× g for 15 min, and supernatants were carefully removed by pipetting. Each pellet was washed twice with 75% ethanol. Finally, RNA pellets were air-dried at room temperature until visually dry (~20 min) and then dissolved in 20 µL nuclease-free water. RNA concentration was measured using a NanoDrop 2000 spectrophotometer (Thermo Fisher).

To extract RNA from larval carcasses, 300 µL of deionized H 2 O was added to the exsanguinated carcass. The carcass was homogenized with a sterile steel BB using a Tis-sueLyzer (Qiagen) at 30 Hz for 2 min. Then, 800 µL TRIzol ® reagent (Invitrogen) was added to the lysate and vortexed and incubated at room temperature for 5 min; 200 µL of chloroform was then added. The tubes were shaken by hand for 15 s and incubated at room temperature for 2 min. The samples were then centrifuged for 15 min at 4 • C at 12,000× g. The aqueous phase was transferred to a clean microcentrifuge tube (approximately 800 µL), one volume of isopropanol was added, and tubes were mixed by inverting. Samples were incubated at −20 • C for one hour and then centrifuged for 10 min at 4 • C at 12,000× g. The supernatant was decanted, and the pellet was washed by adding 500 µL 75% ethanol and centrifuging for 5 min (7500× g) at 4 • C. The supernatant was decanted, and pellets were air-dried at room temperature. Pellets were suspended in 100 µL of dH 2 O.

Reverse transcription (RT) reactions to produce complementary DNA (cDNA) were performed by incubating 100-250 ng total RNA for cultured cell experiments, 200 units M-MLV reverse-transcriptase (Promega), and 500 ng random hexamer primers (IDT) for 2 h at 37 • C, according to the manufacturer's instructions. For larvae/hemocyte assays, 2000 and 1000 ng total RNA, respectively, were used for RT reactions.

Virus-treated samples (with SBV, DWV, or FHV) were analyzed for the presence of the negative-strand RNA of the viral genome (i.e., the replicative intermediate form) using strand-specific PCR [88, 179, 180] . Reverse transcription/cDNA synthesis reactions were performed with M-MLV (Promega) according to the manufacturer's instructions using negative strand-specific primers tagged with an additional 21 nt of sequence at their 5 end (Supplemental Table S1 ). The tag sequence (5 GGCCGTCATGGTGGCGAATAA3 ) shares no homology with the viruses used in this study nor with the honey bee genome. Reactions were carried out by incubating 100-250 ng RNA and primers (10 pmol specific or 500 ng hexamers) with 200 units M-MLV reverse-transcriptase (Promega) according to the manufacturer's instructions. Reverse transcription reactions were incubated for 2 at 37 • C. Unincorporated primers present in the RT reactions were digested with 2 units exonuclease I (Life Technologies) per reaction at 37 • C for 30 min, followed by heat inactivation at 85 • C for 5 min. To detect negative-strand-derived cDNA products, 5 µL of cDNA template in 12.5 µL aqueous buffer containing 10 pmol of each of a tag-specific forward primer (TAGS) and virus-specific reverse primer (Table S1 ) was amplified with 0.5 µL (5 U/µL) ChoiceTaq polymerase (Thomas Scientific) using the following cycling conditions: 95 • C for 5 min; 95 • C for 30 s, 55 • C for 30 s, 72 • C for 45 s, 35 cycles; final elongation 72 • C for 5 min, hold at 4 • C. Negative control PCR reactions were performed using template generated from RNA-containing RT reactions that were incubated in the absence of RT enzyme or using cDNA template that was generated using random-hexamer primers and only including the reverse primer in the PCR. Positive controls included PCR using virus-specific qPCR primers (Supplemental Table S1 ). Viral and other long single-stranded RNA molecules often exhibit secondary structures, which serve to prime reverse transcription reactions in the absence of exogenous primers (i.e., self-priming). To test for self-priming, RT reactions were carried out in the absence of primers, followed by PCR with virus-specific qPCR primers (See Supplemental Table S1 for full list of controls).

PCR was performed according to standard methods [33, 63, 64, 97] . In brief, 2 µL cDNA template in 12.5 µL aqueous buffer containing 10 pmol of each forward and reverse primer (Table S1 ) was amplified with 0.5 µL (5 U/µL) ChoiceTaq polymerase (Thomas Scientific) according to the manufacturer's instructions using the following cycling conditions: 95 • C for 5 min; 95 • C for 30 s, 55 • C for 30 s, 72 • C for 45 s, 35 cycles; final elongation 72 • C for 5 min, hold at 4 • C. PCR products were visualized by 1.5% agarose gel electrophoresis and stained with SYBRsafe (Invitrogen). Positive and negative control reactions were included for all analyses and exhibited the expected results. Select products were purified with the Qiaquick PCR Purification Kit (Qiagen), quantified using a NanoDrop spectrophotometer (Fisher), and Sanger sequenced.

Quantitative PCR (qPCR) was used to quantify the viral RNA (i.e., genome and transcript) abundance in the samples and assess the relative abundances of honey bee encoded transcripts (i.e., a housekeeping gene, rpl8), and three immune genes (i.e., ago2, dcr-like, and bap1/mf116383) using the primer sets listed in Supplemental Table S1 . All qPCR reactions were performed in triplicate using 2 µL of cDNA template and a no-template negative control was run in triplicate for each qPCR reaction. Each 20 µL reaction contained 1× Denville ChoiceTaq Mastermix, 0.4 µM each forward and reverse primer, 1× SYBR Green (Life Technologies), and 3 mM MgCl 2 . Reactions were carried out in 96-well plates using a CFX Connect Real-Time instrument using Maestro software (Bio-Rad) with the following thermo-profile: initial denaturation at 95 • C for one minute; followed by 40 cycles of 95 • C for 10 s, 58 • C for 20 s, and 72 • C for 15 s, with a final melt curve analysis at 65 • C for 5 s to 95 • C. Positive and negative control reactions were included for all qPCR analyses and exhibited the expected results. Viral RNA copies were estimated using a plasmid DNA standard for SBV, DWV, and FHV, with a detection range of 10 3 to 10 9 to create a linear standard curve used for copy number interpolation. The linear equation for the plasmid standard for FHV was Ct = −3.240x + 40.138 (R 2 = 0.980, efficiency = 103%), determined by a previously described method [181] . Similarly, the linear equation for DWV was Ct = −3.5627x + 39.091 (R 2 = 0.9973, efficiency = 90.5%). The linear equation for the SBV standard curve was Ct = −3.39x + 37.42 (R 2 = 0.994, efficiency = 97.2%). The relative expression of host genes was determined by a ranked ∆∆Ct method in which the ∆Ct was calculated by subtracting the rpl8 Ct value from the Ct of the gene of interest. Then, the within-group ∆Ct values were ranked from highest to lowest, and the relevant corresponding control ∆Ct value was subtracted from the treatment group ∆Ct to obtain the ∆∆Ct. The fold-change in cDNA abundance was calculated by the equation 2 −∆∆Ct . See Supplemental Tables S2-S12 for qPCR data presented in the figures.

To prepare hemocytes for imaging, they were isolated as above and seeded into #1.5 German cover glass chamber slides (Thermo Fisher Scientific) in WH2 media. Live-cell and fixed-cell images were taken on a Nikon Ti-Eclipse (Nikon Instruments) inverted microscope equipped with a SpectraX LED (Lumencor) excitation module and fast-switching emission filter wheels (Prior Scientific). Brightfield images were captured using a Plan Fluor 20 phase contrast (Ph) objective and an iXon 896 EM-CCD (Andor Technology Ltd.) camera using NIS Elements software. To visualize cells with an intact nucleus, the cell culture media was removed, and the cells were washed with PBS and then incubated in 4% paraformaldehyde in PBS for 10 min at room temperature. The paraformaldehyde containing PBS was removed, and cells were washed two times with PBS. Hoechst stain (Hoechst 33258, Invitrogen) prepared to 30 mg/mL in PBS was further diluted 1:5000 in PBS to create a working solution, which was then overlaid on the cells. Then, fluorescent images were captured using paired excitation/emission filters and dichroic mirrors for DAPI (Chroma Technology Corp).

All data were analyzed using R v4.0.2 in RStudio V1.3.1073. Unless otherwise stated, comparisons for virus abundance were evaluated using the DunnettTest function in the DescTools R stats package to perform the post hoc pairwise multiple comparisons to a control [182] . Relative gene expression differences were evaluated using a one-sided Wilcoxon [183] . For each analysis, comparisons were considered significant if p < 0.05.

To determine whether sacbrood virus (SBV) infects hemocytes, the primary immune cell in honey bees, approximately 1 × 10 5 larval (L4-L5) hemocytes were seeded into wells of a 48-well tissue culture plate with relatively few contaminating adipocytes and treated with either phosphate buffered saline (PBS) or SBV (i.e., bee larval lysate containing 2.5 × 10 6 SBV RNA copies) (Supplemental Figure S1 ). Cells were harvested at distinct time points post-infection (i.e., from 0 hours post-infection (hpi) to 96 hpi) and virus abundance, using RNA copy number as a proxy, was determined by qPCR. In one experimental replicate, the primary honey bee hemocyte culture had a pre-existing SBV infection, which exhibited a 501× increase in SBV by 96 h post-treatment (p = 0.042) ( Figure 1A ). This result indicates that hemocytes are a natural site of SBV infection and that SBV virus infections can persist in cells grown in culture. The addition of SBV increased the infection level by 13× over the initial levels by 24 hpi (p < 0.001), and it rose to 69.2× by 48 hpi (p < 0.001), to 147.9× by 72 hpi (p < 0.0001), and peaked at 354.8× at 96 hpi (p < 0.0001). In a second biological replicate of this experiment, confounding SBV infection was not detected ( Figure 1B ). In inoculated hemocytes, there was a 24× increase from 0 hpi to 24 hpi (p = 0.0001), and by 48 hpi SBV had increased 182× (p < 0.0001) and reached peak infection. There was a decrease in SBV relative to 48 hpi at 72 hpi (i.e., 49× greater virus levels than at 0 hpi, p < 0.0001), with a subsequent rise at 96 hpi (i.e., 132× increase over 0 hpi, p < 0.0001). Although it is unclear why there was a reduction in viral abundance at 72 hpi, it could have been due to a decrease in the number of permissive hemocytes in the culture; by 96 hpi, cell division and/or differentiation may have occurred and resulted in additional susceptible host cells.

To further validate that the increase in SBV over the infection time course was due to active virus replication in honey bee hemocytes, we carried out strand-specific RT-PCR. The SBV genome is positive-sense single-stranded RNA (+ssRNA). During virus replication, a negative strand template is produced [88, 179, 180, 184] . The negative strand of SBV was not detected in the inoculum (i.e., at 0 hpi), but was detected at all other time points ( Figure 1C ). Together these data indicate that not only does SBV actively replicate in hemocytes, but hemocytes also serve as a natural site of virus infection. Furthermore, virus testing of honey bee larvae (i.e., corresponding carcass and hemocyte samples) indicate that hemocytes are natural sites of infection for black queen cell virus (BQCV) (Supplemental Table S24 ). While, in general, hemocytes had low incidence of infection, isolated larval hemocytes were positive for BQCV in 9.1% of cases where the larval carcass was also BQCV-positive (Supplemental Table S24 ). Together, these data suggest hemocytes might be a site of infection for multiple viruses. These results are in line with reports of virus infections in other invertebrates, including persistent infection of hemocytes by hepatitis A virus (HAV) and murine norovirus (MNV) in oysters (Crassostrea virginica) [185] . In addition, white spot syndrome virus (WSSV) infects subpopulations of shrimp hemocytes [186] . Results from honey bees, oysters, and shrimp differ from the observation that hemocytes of Sindbis-virus-infected Drosophila melanogaster remain uninfected [170] . As described above, hemocytes consist of several subpopulations. Future studies aimed at identifying the hemocyte subpopulations that are permissive to specific viruses will provide insight into the role of these important immune cells in virus dissemination and antiviral defense. Understanding how viruses interact with hemocytes and how they might frustrate the cellular immune function may aid in the long-term goal of developing therapeutics and technologies that mitigate the negative impacts of viruses on bees.

virus infections in other invertebrates, including persistent infection of hemocytes by hepatitis A virus (HAV) and murine norovirus (MNV) in oysters (Crassostrea virginica) [185] . In addition, white spot syndrome virus (WSSV) infects subpopulations of shrimp hemocytes [186] . Results from honey bees, oysters, and shrimp differ from the observation that hemocytes of Sindbis-virus-infected Drosophila melanogaster remain uninfected [170] . As described above, hemocytes consist of several subpopulations. Future studies aimed at identifying the hemocyte subpopulations that are permissive to specific viruses will provide insight into the role of these important immune cells in virus dissemination and antiviral defense. Understanding how viruses interact with hemocytes and how they might frustrate the cellular immune function may aid in the long-term goal of developing therapeutics and technologies that mitigate the negative impacts of viruses on bees. SBV abundance was assessed in mock-or SBV-treated larval hemocytes by qPCR over a time course (i.e., 0 hpi, 24 hpi, 48 hpi, 72 hpi, and 96 hpi). (A) Cells isolated from asymptomatic larvae and treated with PBS (pH 7.4) had a 501× increase in mean SBV abundance by 96 hpi relative to 0 hpi (p = 0.042), indicating that the hemocytes in this experimental replicate had a pre-existing SBV infection and that hemocytes are a natural site of infection for SBV. The addition of filtered larval lysate containing 2.5 × 10 6 SBV RNA copies resulted in a 13× increase by 24 hpi relative to 0 hpi (p < 0.001) and a peak fold increase of 355× by 96 hpi (p < 0.0001). (B) In a second replicate of the experiment, mock-infected cells remained uninfected over the course of the experiment. The addition of filtered larval lysate containing 2.5 × 10 6 SBV RNA copies resulted in a peak fold increase of 182× (p < 0.0001) at 48 hpi, with a decrease at 72 hpi (49× relative to 0 hpi, p < 0.0001) and a subsequent rise again at 96 hpi (132× relative to 0 hpi, p < 0.0001). Raw data are included in Supplemental Table S2 . All differences in means relative to 0 hpi were assessed by a Dunnett's test. Significance levels: * p < 0.05; *** p < 0.0005. (C) To confirm that SBV was productive in infecting larval hemocytes, the presence of the negative strand (a replicative intermediate) was assessed by negative-strand-specific reverse transcription (RT) followed by PCR. Negative strand was detected at all time ) had a 501× increase in mean SBV abundance by 96 hpi relative to 0 hpi (p = 0.042), indicating that the hemocytes in this experimental replicate had a pre-existing SBV infection and that hemocytes are a natural site of infection for SBV. The addition of filtered larval lysate containing 2.5 × 10 6 SBV RNA copies resulted in a 13× increase by 24 hpi relative to 0 hpi (p < 0.001) and a peak fold increase of 355× by 96 hpi (p < 0.0001). (B) In a second replicate of the experiment, mock-infected cells remained uninfected over the course of the experiment. The addition of filtered larval lysate containing 2.5 × 10 6 SBV RNA copies resulted in a peak fold increase of 182× (p < 0.0001) at 48 hpi, with a decrease at 72 hpi (49× relative to 0 hpi, p < 0.0001) and a subsequent rise again at 96 hpi (132× relative to 0 hpi, p < 0.0001). Raw data are included in Supplemental Table S2 . All differences in means relative to 0 hpi were assessed by a Dunnett's test. Significance levels: * p < 0.05; *** p < 0.0005. (C) To confirm that SBV was productive in infecting larval hemocytes, the presence of the negative strand (a replicative intermediate) was assessed by negative-strand-specific reverse transcription (RT) followed by PCR. Negative strand was detected at all time points after 0 hpi. Additional control reactions were performed using pooled RNA from time points 24-96 hpi (Lanes labeled 1-9). Specifically, RNA isolated from SBV containing cell lysate was reverse transcribed with the primer listed below, treated with Exonuclease I to remove excess primer, and amplified using the PCR primers listed for each lane. Table S25 . When reverse transcription was performed without primer, SBV cDNA was detectable (lane 7), indicating that the secondary structure in the RNA genome may serve as a primer for cDNA synthesis.

To our knowledge, this is the first quantitative evidence that SBV productively infects honey bee hemocytes. A previous study used transmission electron microscopy to visualize SBV virions within larval and adult hemocytes [168] . While those images indicated that SBV may replicate in hemocytes, they could have also been explained by phagocytosis of virions [168] . The observation that honey bee hemocytes are naturally infected by SBV has important implications for viral pathogenesis. While we did not observe any cytopathic effects (CPEs), it is possible the cells would have shown CPEs if the experiments were carried out for a longer time period. Additionally, the immune function of hemocytes may be dysregulated by viral infection, since viruses subvert cellular processes and disrupt cellular homeostasis [187, 188] . For example, DWV suppresses larval melanization in response to wounding, suggesting an interaction between DWV and hemocytes [96] . This is further supported by gene expression studies of DWV-infected larvae, which exhibited reduced expression of Amel\102, a gene involved in melanization and encapsulation [96] .

In addition to hosting viral infection, honey bee hemocytes are likely instrumental in antiviral immune responses, as they are in Drosophila melanogaster. Direct evidence for an antiviral role for hemocytes in fruit flies includes the results of in vivo experiments in which hemocytes were either saturated via injection of latex beads or genetically depleted [189] . Flies with reduced hemocyte function that were infected with either Cricket paralysis virus (CrPV), FHV, or vesicular stomatitis virus (VSV) had increased viral abundance and higher mortality than flies with phagocytic hemocytes. In contrast, reduced hemocyte function had no impact on Drosophila C virus (DCV), Sindbis virus (SINV), and Invertebrate iridescent virus 6 (IIV6) infections in flies [189] . These results also indicated that the relative importance of hemocytes in host antiviral defense will vary for specific host-virus pairs and may also depend on additional factors (e.g., co-infection, nutritional status, age). Hemocytes are required for systemic adaptive RNAi response in flies, which limits virus infection [170, 171] . This finding provides strong support for an antiviral role of hemocytes against some viruses in fruit flies, which suggests that hemocytes likely serve an antiviral role in insects in general.

While the function of hemocytes in honey bee antiviral response requires further investigation, there is limited indirect evidence of their antiviral role. Specifically, genes involved in migration, phagocytosis, and expression immunoglobulin domain encoding, were expressed at greater levels in honey bees infected with a model virus, SINV, relative to mock-infected bees [107] . Additionally, IAPV infection resulted in increased expression of genes involved in cell projection, cellular organization, autophagic cell death, microtubulebased movement, and phagocytosis [101, 190] . Our observation that viruses replicate in cultured hemocytes will facilitate future studies aimed at elucidating their role in antiviral defense, including further investigation of the genes and processes highlighted by transcriptional level studies.

To determine whether a mixed cell culture derived from purple-eyed pupae supported SBV infection, approximately 1 × 10 6 cells were treated with either PBS or SBV (i.e., bee larval lysate containing 2.5 × 10 6 SBV RNA copies). Cells were harvested at distinct time points post-infection, and virus abundance was assessed by qPCR. Three independent experiments were performed (Supplemental Figure S2 ). In replicate one, SBV abundance was 7.8× higher by 48 hpi than the levels after 0 hpi (p < 0.0001). SBV abundance remained high at 72 hpi (12×, p < 0.0001) and 96 hpi (11.4×, p < 0.0001) (Supplemental Figure S2A) . Likewise, in the second experimental replicate, SBV abundance was higher by 48 hpi (59×, p < 0.0001), remained high at 72 hpi (126×, p < 0.001), and peaked at 96 hpi (1047×, p < 0.0001) (Figure 2A and Figure S2B ). While SBV levels at 24 hpi were close to the levels of the 0 hpi time points in the first two biological replicates, they were significantly lower in replicate three (i.e., 0.017×, p < 0.0001). Like the other two replicates, SBV levels increased by 48 hpi (2.2×, p = 0.0012), remained high at 72 hpi (14×, p = 0.00013), and peaked at 96 hpi (72×, p < 0.0001) (Supplemental Figure S2C ). The overall increase in SBV levels for replicate three was 1,817× (i.e., from 24 hpi to 96 hpi (p < 0.0001)), which was similar to replicate two, which had an overall 1047× increase, whereas the replication and relative increase in abundance for replicate one was lower (i.e., only 72×) (Supplemental Figure S2A) . To further verify that SBV productively infected cultured honey bee pupal cells, we used strand-specific RT-PCR to assay for the negative strand (i.e., replicative intermediate form of SBV). The SBV-negative strand was detected at three time points post-infection, which corresponded to peak virus abundances (i.e., 48, 72, and 96 hpi) ( Figure 2B ). Together, these data demonstrate that primary honey bee pupal cell cultures are permissive to SBV infection. Furthermore, since the fold increase of SBV in honey bee pupal cells was greater than in hemocytes, we hypothesize that cell types present in pupal cultures, including endothelial cells and fibroblasts, may be more suitable hosts for SBV compared to immune cells.

remained high at 72 hpi (12×, p < 0.0001) and 96 hpi (11.4×, p < 0.0001) (Supplemental Figure S2A) . Likewise, in the second experimental replicate, SBV abundance was higher by 48 hpi (59×, p < 0.0001), remained high at 72 hpi (126×, p < 0.001), and peaked at 96 hpi (1047×, p < 0.0001) (Figures 2A and S2B ). While SBV levels at 24 hpi were close to the levels of the 0 hpi time points in the first two biological replicates, they were significantly lower in replicate three (i.e., 0.017×, p < 0.0001). Like the other two replicates, SBV levels increased by 48 hpi (2.2×, p = 0.0012), remained high at 72 hpi (14×, p = 0.00013), and peaked at 96 hpi (72×, p < 0.0001) (Supplemental Figure S2C ). The overall increase in SBV levels for replicate three was 1,817× (i.e., from 24 hpi to 96 hpi (p < 0.0001)), which was similar to replicate two, which had an overall 1047× increase, whereas the replication and relative increase in abundance for replicate one was lower (i.e., only 72×) (Supplemental Figure  S2A ). To further verify that SBV productively infected cultured honey bee pupal cells, we used strand-specific RT-PCR to assay for the negative strand (i.e., replicative intermediate form of SBV). The SBV-negative strand was detected at three time points post-infection, which corresponded to peak virus abundances (i.e., 48, 72, and 96 hpi) ( Figure 2B ). Together, these data demonstrate that primary honey bee pupal cell cultures are permissive to SBV infection. Furthermore, since the fold increase of SBV in honey bee pupal cells was greater than in hemocytes, we hypothesize that cell types present in pupal cultures, including endothelial cells and fibroblasts, may be more suitable hosts for SBV compared to immune cells. Table S3 . See Supplemental Figure S2 for additional replicates. All differences in means relative to 0 hpi were assessed by a Dunnett's test. Significance levels: *** p < 0.0005. (B) To confirm that SBV was productive in infecting larval hemocytes, the presence of the negative strand (a replicative intermediate) was assessed by negative strand-specific reverse transcription (RT) followed by PCR. Negative strand was detected at all time points after 24 hpi. Additional control reactions were performed using pooled RNA from time points 24-96 hpi (Lanes labeled 1-9). Specifically, RNA isolated from SBV containing cell lysate was reverse-transcribed with the primer listed below, treated with Exonuclease I to remove excess primer, and amplified using the PCR primers listed for each lane. While the primary concern of SBV infection of honey bee colonies is larval mortality, SBV also reduces adult lifespan. SBV infections in pupae may inhibit the melanization pathway by causing reduced expression of prophenoloxidase activating enzyme (PPAE) and increased expression of a putative serpin protein encoding gene (GB48820) [59, 145] . Pupae with a suppressed melanization response may be more susceptible to infection after wounding by Varroa destructor mites. It is not known whether SBV-infected pupae can clear infections prior to eclosion, and in turn if SBV-infected pupae can develop into healthy adults. Therefore, tools to study the impact of SBV and the molecular mechanisms of antiviral defense at all life stages are needed and include the SBV-permissive cultured primary cells described herein.

To investigate the utility of primary honey bee pupal cells to support DWV infection, approximately 1 × 10 6 purple-eyed pupal cells were incubated with 4.3 × 10 6 DWV RNA copies. Cells were harvested at distinct time points post-infection (i.e., from 0 hpi to 96 hpi), and virus abundance, using RNA copy number as a proxy, was determined by qPCR. Data from two independent experiments demonstrated that DWV abundance increased from 0 hpi to 96 hpi (Supplemental Figure S3 ). In replicate one, DWV levels remained unchanged for the first 24 h and were 2.7× greater at 48 hpi (p = 0.002). DWV abundance increased 3.5× and 4× at 72 hpi (p < 0.001) and 96 hpi (p < 0.001), respectively, with peak DWV levels at 96 hpi relative to 0 hpi ( Figure 3A ). In replicate two, DWV levels remained similar to inoculum levels through 48 hpi but were 3.2× higher at 72 hpi (p = 0.001) and 6.6× higher at 96 hpi, relative to 0 hpi (p = 0.003) (Supplemental Figure S3 ). To verify DWV replication in primary cultures of purple-eyed honey bee pupal cells, negative-strand specific PCR was performed, and the replicative intermediate form (i.e., negative strand) of DWV was detected at 72 hpi ( Figure 3B ). Together, DWV abundance and negative-strand data confirm that primary cultures of honey bee pupal cells support DWV replication.

The ability to infect primary honey bee cells with DWV opens new avenues for studying a pathogen that has co-evolved with honey bees. Primary cell cultures may also facilitate the propagation of virus stocks that are free of confounding viruses. Experiments in cultured honey bee cells also provide an opportunity to study the mechanistic details of DWV infections and virus-host dynamics in a system that complements experiments carried out in larvae, pupae, and adult honey bees. Recent efforts have focused on exploring the ability of alternative host cell lines to support honey bee virus infections; for example, the Lepidopteran hemocyte-derived cell line (P1) has been shown to support DWV infection [151] . While exploring the ability of alternative cell lines to support honey bee virus infections is an attractive approach, the immune response elicited by these alternative host cells may or may not completely recapitulate the immune response elicited by honey bees. Therefore, the potential to infect primary honey bee cells with naturally infecting honey bee viruses, including DWV, will be a powerful tool to explore the natural host-virus interactions at the cellular level.

To investigate the ability of honey bee immune cells to support the replication of a model virus, approximately 1 × 10 5 larval-derived hemocytes maintained in culture were incubated with PBS or FHV (1 × 10 6 FHV RNA copies). Cells were harvested at distinct time points post-infection (i.e., from 0 hpi to 96 hpi), and virus abundance was determined by qPCR. Data from two independent experiments demonstrated that FHV abundance increased from 0 hpi to 72 hpi and decreased from 72 hpi to 96 hpi (Supplemental Figure S4 ). In replicate one, FHV levels in hemocytes increased 3.7× by 24 hpi (p = 0.026) and 10.7× by 48 hpi, relative to 0 hpi (p < 0.001) ( Figure 4A ). FHV abundance continued to increase from 48 hpi to 72 hpi, which had 37× (p < 0.001) the initial FHV level (i.e., compared to 0 hpi) ( Figure 4A ). By 96 hpi, FHV abundance was less than levels quantified at 72 hpi (p = 0.034) but remained significantly higher relative to 0 hpi (p < 0.001) ( Figure 4A ). One possible explanation for reduced FHV abundance at 96 hpi is that, by that time most hemocytes were FHV-infected, there may have been a lack of naïve host cells to support further virus replication. In replicate two of this experiment, FHV abundance was constant at 24 hpi but was 16× higher at 48 hpi (p < 0.01) relative to 0 hpi. At 72 hpi, FHV levels peaked, with 39.8× higher FHV levels compared to 0 hpi (p < 0.001). FHV abundance was reduced at 96 hpi relative to 72 hpi but was still 12.6× higher that levels at 0 hpi (p < 0.001) (Supplemental Figure S4B) . To further validate that FHV, which has a +ssRNA genome, productively infected cultured honey bee hemocytes, negative-strand-specific PCR was utilized to detect the replicative intermediate of FHV. Since FHV abundance peaked at 72 hpi, this time point was selected to assay for the presence of negative strand, and a negative-strand-specific FHV PCR product was detected ( Figure 4B ). Together, FHV abundance and negative-strand data demonstrate that FHV productively infects primary honey bee hemocytes maintained in culture. Supplemental Table S25 .

The ability to infect primary honey bee cells with DWV opens new avenues for studying a pathogen that has co-evolved with honey bees. Primary cell cultures may also facilitate the propagation of virus stocks that are free of confounding viruses. Experiments in cultured honey bee cells also provide an opportunity to study the mechanistic details of DWV infections and virus-host dynamics in a system that complements experiments carried out in larvae, pupae, and adult honey bees. Recent efforts have focused on exploring the ability of alternative host cell lines to support honey bee virus infections; for example, the Lepidopteran hemocyte-derived cell line (P1) has been shown to support DWV infection [151] . While exploring the ability of alternative cell lines to support honey bee Supplemental Table S25 .

The ability to infect hemocytes with FHV provides an additional tool for investigating virus-honey bee host interactions at the cellular level. This model virus may prove particularly useful in investigating RNAi in the context of viral suppressors, since FHV-B2 protein suppresses RNAi, as confirmed by studies that utilized deletion mutants (i.e., FHV-∆B2) [128, 191] . To date there have been relatively few studies on putative bee virusencoded VSRs, and the results from IAPV-infected honey bees and bumble bees have mixed results regarding the presence of a VSR; therefore, additional investigation is required [150, 190] . The proteins produced by other model insect viruses, including cricket paralysis virus and Drosophila C virus, which encode bona fide VSRs, have a conserved amino acid motif (DvExNPGP) downstream of their VSR proteins [192, 193] . Sequence analysis indicates that this motif is present in IAPV, KBV, and ABPV, suggesting that these viruses may encode VSRs, although additional studies are needed to identify and validate putative VSRs. Overall, the use of both model viruses and naturally infecting honey bee viruses, including those that do and do not encode RNAi suppressors, will advance our knowledge of the interactions between viruses and the host antiviral RNAi machinery.

host-virus interactions at the cellular level.

To investigate the ability of honey bee immune cells to support the replication of a model virus, approximately 1 × 10 5 larval-derived hemocytes maintained in culture were incubated with PBS or FHV (1 × 10 6 FHV RNA copies). Cells were harvested at distinct time points post-infection (i.e., from 0 hpi to 96 hpi), and virus abundance was determined by qPCR. Data from two independent experiments demonstrated that FHV abundance increased from 0 hpi to 72 hpi and decreased from 72 hpi to 96 hpi (Supplemental Figure  S4 ). In replicate one, FHV levels in hemocytes increased 3.7× by 24 hpi (p = 0.026) and 10.7× by 48 hpi, relative to 0 hpi (p < 0.001) ( Figure 4A ). FHV abundance continued to increase from 48 hpi to 72 hpi, which had 37× (p < 0.001) the initial FHV level (i.e., compared to 0 hpi) ( Figure 4A ). By 96 hpi, FHV abundance was less than levels quantified at 72 hpi (p = 0.034) but remained significantly higher relative to 0 hpi (p < 0.001) ( Figure 4A ). One possible explanation for reduced FHV abundance at 96 hpi is that, by that time most hemocytes were FHV-infected, there may have been a lack of naïve host cells to support further virus replication. In replicate two of this experiment, FHV abundance was constant at 24 hpi but was 16× higher at 48 hpi (p < 0.01) relative to 0 hpi. At 72 hpi, FHV levels peaked, with 39.8× higher FHV levels compared to 0 hpi (p < 0.001). FHV abundance was reduced at 96 hpi relative to 72 hpi but was still 12.6× higher that levels at 0 hpi (p < 0.001) (Supplemental Figure S4B ). To further validate that FHV, which has a +ssRNA genome, productively infected cultured honey bee hemocytes, negative-strand-specific PCR was utilized to detect the replicative intermediate of FHV. Since FHV abundance peaked at 72 hpi, this time point was selected to assay for the presence of negative strand, and a negative-strandspecific FHV PCR product was detected ( Figure 4B ). Together, FHV abundance and negative-strand data demonstrate that FHV productively infects primary honey bee hemocytes maintained in culture. Table S5 . Figure 4 includes results from one representative biological replicate. The data for additional replicates are presented in Supplemental Figure S4 . All differences in means relative to 0 hpi were assessed by a Dunnett's test. Significance levels: * p < 0.005; *** p < 0.0005. (B) FHV-specific negative strand was detected at 72 hpi, which confirms that FHV productively infects primary honey bee hemocytes (Lane 1). Additional control reactions were performed using pooled RNA from time points 24-96 hpi (Lanes labeled 2-9). Specifically, RNA-isolated FHV containing cell lysate was reverse-transcribed with the primer listed below, treated with Exonuclease I to remove excess primer, and amplified using the PCR primers listed for each lane. Supplemental Table S25 .

To examine the ability of cells derived from purple-eyed honey bee pupae to support infection and replication of FHV, approximately 1 × 10 6 primary cells in culture were incubated with FHV (2 × 10 8 FHV RNA copies), and virus abundance was assessed at distinct time points post-infection. FHV abundance increased from 0 hpi to 72 hpi and was reduced or remained constant at 96 hpi in two experimental replicates. In replicate one, FHV levels increased by 1.7× at 24 hpi (p = 0.024) and by 3.4× at 48 hpi, relative to initial levels at 0 hpi (p < 0.001). The peak of infection was reached at 72 hpi, with 5× greater FHV levels relative to 0 hpi (p < 0.001). FHV abundance in pupal cells did not increase from 72 hpi to 96 hpi but remained 4× higher than at 0 hpi (p < 0.001) ( Figure 5A) . Similarly, in the second biological replicate, FHV abundance was 2.6× higher at 24 hpi (p = 0.013) and 7.5× higher at 48 hpi (p < 0.001), relative to levels at 0 hpi. FHV abundance increased 20× (p < 0.001) at 72 hpi relative to 0 hpi, which was the peak of virus infection. Similar to FHV infection in hemocytes, FHV levels in pupal cells was lower at 96 hpi relative to 72 hpi (p < 0.01) but was still 15.8× higher at 96 hpi compared to 0 hpi (p < 0.001) (Supplemental Figure S5B ). To validate that the increase in FHV abundance was indicative of virus replication, the presence of FHV negative strand was assayed using strand-specific PCR. Active replication of FHV was confirmed by detection of FHV negative-strand PCR product at 72 hpi ( Figure 5B ). Together, the increase in FHV abundance quantified over the course of infections and the detection of the replicative intermediate form (i.e., negative strand) of FHV demonstrate that primary honey bee cells derived from purple-eyed pupae support the replication of FHV.

The ability to infect mixed cell types derived from honey bee pupae with a model virus helps address some challenges in studying honey bee host-virus interactions using naturally infecting honey bee viruses. FHV can be easily propagated and purified in the lab, which helps circumvent the problem of mixed virus inoculum produced from infected bees, since many honey bee viruses co-purify due to their similar size and the high prevalence of mixed infections in colonies [10, 40, 52, 63, 64, 97] . Since FHV does not naturally infect honey bees, the experimental results may not be confounded by pre-existing infections. However, a limitation of using FHV as a model virus to investigate honey bee antiviral defense mechanisms is that it does not naturally infect honey bees and therefore may not induce the same broad-spectrum antiviral or virus-specific immune responses that occur during infection with a co-evolved virus. One benefit to utilizing FHV in studies aimed at elucidating honey bee antiviral defense is that FHV-host interactions have been studied in a broad range of insect hosts, including mosquitoes, fruit flies, honey bees, tsetse flies, and reduviid bugs, thus facilitating comparative immune studies [105, 106, 110, 111] .

To determine if FHV infection can be transferred from FHV-infected honey bee pupal cells to naïve cells, virus-containing cell culture obtained during peak infection (i.e., 72 hpi) was transferred to naïve pupal cells. Virus abundance in the secondary host cells was monitored over time. In replicate one, a small volume of FHV-infected pupal cell culture (i.e., 10 µL with 2.6 × 10 8 FHV RNA copies) was transferred to freshly seeded pupal cells ( Figure 6A ). FHV abundance at 48 hpi was 15.8× greater (p = 0.003) and at 72 hpi 28× greater than levels at 0 hpi (p < 0.001). In the second replicate, FHV-infected pupal cells (i.e., 10 µL infected cell culture with 2.9 × 10 8 FHV RNA copies) from the first round of infection were transferred to naïve pupal cells, and FHV abundance remained constant from 0 hpi to 48 hpi but was 10.4× higher at 72 hpi (p < 0.001) (Supplemental Figure S6B ). As expected, FHV was not detected in control experiments, in which a small volume of mock-infected honey bee pupal cell culture was transferred to naïve cells ( Figure 6A and Figure S6B ). Together these results confirm that FHV virions produced by primary honey bee pupal cell cultures can be utilized to established new/secondary infections ( Figure 6A ). viral defense mechanisms is that it does not naturally infect honey bees and therefore may not induce the same broad-spectrum antiviral or virus-specific immune responses that occur during infection with a co-evolved virus. One benefit to utilizing FHV in studies aimed at elucidating honey bee antiviral defense is that FHV-host interactions have been studied in a broad range of insect hosts, including mosquitoes, fruit flies, honey bees, tsetse flies, and reduviid bugs, thus facilitating comparative immune studies [105, 106, 110, 111] . Supplemental Table S25 .

(i.e., 10 μL infected cell culture with 2.9 × 10 FHV RNA copies) from the first round of infection were transferred to naïve pupal cells, and FHV abundance remained constant from 0 hpi to 48 hpi but was 10.4× higher at 72 hpi (p < 0.001) (Supplemental Figure S6B ). As expected, FHV was not detected in control experiments, in which a small volume of mock-infected honey bee pupal cell culture was transferred to naïve cells (Figures 6A and  S6B ). Together these results confirm that FHV virions produced by primary honey bee pupal cell cultures can be utilized to established new/secondary infections ( Figure 6A) . Figure 6 includes results from one representative biological replicate. The data for additional replicates are presented in Supplemental Figure S6 . All differences in means relative to 0 hpi were assessed by a Dunnett's test. Significance levels: ** p < 0.005; *** p < 0.0005.

To determine if the DWV-infected cultured primary honey bee pupal cells produced infectious virions, small volumes of DWV-infected cell cultures were transferred to naïve cultured pupal cells. In replicate one, naïve honey bee pupal cells were treated with cells and cell culture supernatant (10 µL) from either mock-infected or DWV-infected cultures, which contained an equivalent of 1.04 × 10 5 DWV RNA copies. By 48 hpi, DWV abundance increased 2.7× relative to 0 hpi (p < 0.001). DWV levels continued to increase over time, with 4.1× increase at 72 hpi (p < 0.001) ( Figure 6B ). In replicate two, naïve pupal cells were treated with 10 µL DWV-infected pupal cells (i.e., 9 × 10 4 DWV RNA copies). DWV abundance increased by 2.3× at 48 hpi (p < 0.01) and was 10.4× greater at 72 hpi, relative to 0 hpi (p < 0.001) (Supplemental Figure S6D ). As expected, DWV was not detected in mock-infected cells, in which a small volume of PBS-treated honey bee pupal cell culture was transferred to naïve cells. The increase in DWV abundance over time and detection of negative strand suggest that the DWV infection in honey bee pupal cells results in the production of infectious DWV virions that have the ability to infect naïve host cells.

Honey bee primary cells will be an important tool to investigate honey bee antiviral defense mechanisms. We hypothesized that differential transcription of immune genes in primary cultures will reflect the transcriptional response in individuals (i.e., pupae or adults) [86, 100, 101, 107, 108, 145, 146, 190] . Therefore, to begin to characterize cellular-level honey bee antiviral immune responses, honey bee pupal cells were infected with SBV, DWV, or FHV, and the expression of select antiviral genes, including dicer-like (dcr-like), argonaute-2 (ago2), and bee antiviral protein-1 (bap1), which was formerly designated as GenBank MF116383, were analyzed by qPCR in either two or three experimental replicates (Figure 7 and Supplemental Figures S7-S10) . primary cultures will reflect the transcriptional response in individuals (i.e., pupae or adults) [86, 100, 101, 107, 108, 145, 146, 190] . Therefore, to begin to characterize cellular-level honey bee antiviral immune responses, honey bee pupal cells were infected with SBV, DWV, or FHV, and the expression of select antiviral genes, including dicer-like (dcr-like), argonaute-2 (ago2), and bee antiviral protein-1 (bap1), which was formerly designated as Gen-Bank MF116383, were analyzed by qPCR in either two or three experimental replicates (Figure 7 and Supplemental Figures S7-S10 ). Overall, the expression of bap1 (GenBank: MF116383) was greater in SBV-infected cells than mock-infected pupal cells at 72 hpi. Specifically, in first biological replicate, bap1 expression was 0.67 log 2 -fold greater in SBV-infected pupal cells relative to the expression level in mock-infected cells (Wilcoxon Rank Sums, p = 0.032) (Supplemental Figure S7C) . Likewise, bap1 expression was greater in the second biological replication (0.95 log 2 -fold, p = 0.032, Figure 7A ) but not the third. Since the bap1 expression was greater two of the three biological replicates of SBV-infected pupal cells, its expression in the third biological replicate was also assessed at 96 hpi, at which time its expression was 0.73 log 2 -fold higher in SBV-infected cells relative to mock-infected cells (p = 0.032) (Supplemental Figure S7C ). Expression of neither ago2 nor dcr-like were appreciably impacted by SBV infection. Specifically, ago2 was not differentially expressed in the first two replicates but had −0.76 log 2 -fold lower expression in the third replicate (p = 0.032) ( Figure 7A and Figure S7A ). Similarly, dcr-like was not differentially expressed in the second replicate but exhibited −0.67 log 2 -fold lower expression in the third replicate (p = 0.032) (Supplemental Figure S7 ). In DWV-infected pupal cells, bap1 expression was unchanged in one replicate (Supplemental Figure S8C ) and slightly greater in the second experimental replicate relative to mock-infected cells at 72 hpi (0.18 log 2 -fold change, p = 0.032, Figure 7B ). In DWVinfected pupal cells, ago2 expression was slightly lower compared to mock-infected cells in two biological replicates (−0.28 and −0.18 log 2 -fold change, p = 0.032, Figure 7B and Figure S8A ). In contrast, dcr-like expression was slightly lower in DWV-infected pupal cells in one replicate (−0.26 log 2 -fold, p = 0.032, Figure S8B ), while its expression was similar to mock-infected cells in another replicate (Supplemental Figure S7B ). The expression of bap1 was not appreciably impacted by FHV infection of pupal cells ( Figure 7C and Figure S9C ). Specifically, bap1 expression was slightly lower in one replicate (−0.4 log 2 -fold, p = 0.032) and unchanged in the second replicate, compared to mock-infected cells ( Figure 7C and Figure S9C ). Interestingly, ago2 expression was consistently higher in FHV-infected cells relative to mock-infected cells in two replicates (i.e., 1 log 2 -fold in rep1 and 1 log 2 -fold in rep2, p = 0.032) ( Figure 7C and Figure S9A ). Similarly, dcr-like expression was greater in FHV-infected cells relative to mock-infected cells in both replicates (i.e., 0.66 log 2 -fold in rep1 and 0.48 log 2 -fold in rep2, p = 0.032) ( Figure 7C and Figure S9B ). The trends in immune gene expression in FHV-infected hemocytes were similar to FHV-infected pupal cells (Supplemental Figure S10) . Specifically, bap1 expression was similar in FHV-infected and mock-infected cells at 72 hpi, whereas FHV-infected hemocytes exhibited greater ago2 (i.e., 1.1 log 2 -fold in rep1 and 0.54 log 2 -fold in rep2, p = 0.032) and dcr-like expression (i.e., 0.45 log 2 -fold in rep1 and 0.63 log 2 -fold in rep2, p = 0.032) than mock-infected hemocytes in both biological replicates (Supplemental Figure S10 ).

Together these experiments indicate that studies in cultured honey bee primary cells recapitulate data obtained from transcriptome level studies in individual honey bees, including those carried out in pupae and adult bees [100] , though additional studies are needed to better assess honey bee antiviral immune responses at the cellular level. Further development, including the advancements described herein, and utilization of honey bee primary cells is integral to elucidating the defense pathways important for specific virus infections and, in turn, identifying viral counter defense strategies.

In summary, these data indicate that primary honey bee cell cultures of larval hemocytes and explanted pupal tissue serve as a useful tool for studying honey bee-host interactions. In addition to demonstrating that a panel of viruses (SBV, DWV, and FHV) replicates in hemocytes and/or pupal cells, pupal cell cultures showed virus-specific transcriptional regulation of three immune genes (dcr-like, ago2, and bap1). These cultures can be established using rather simple techniques that are amenable to higher sample size studies. Future work to optimize transfection in these different cell culture types will be paramount for performing more advanced mechanistic studies. This includes utilizing RNAi-mediated gene knockdown, which facilitates the study of honey bee host-virus interactions by directly demonstrating the importance of specific genes in limiting particular viruses. For example, this study indicates that hemocytes are a natural site of infection for SBV and that SBV results in higher bap1 expression in infected pupal cells. By reducing the expression of bap1 in cell cultures that are infected with SBV, one could test the hypothesis that this gene is important for cells to combat SBV infection. Additionally, the use of cell culture will facilitate the study of basic virological questions, including virus cellular tropism, entry, and uncoating mechanisms. Additional efforts to establish virus-free cell lines from explanted honey bee tissues will prove useful for the production of pure virus stocks, especially in concert with the development of cDNA clones capable of producing infectious virus. The data presented in this study represent one of many steps toward the development of sophisticated cell culture techniques for the study of honey bee host-virus interactions. Table S1 . Primers used in this study. Supplemental Table S2 . Raw data for SBV-infected hemocytes (Figure 1 ). Supplemental Table S3 . Raw data for SBV-infected purple-eyed pupal cells (Figure 2 and Figure S2 ). Supplemental Table S4 . Raw data for DWV-infected purple-eyed pupal cells (Figure 3 and Figure S3 ). Supplemental Table S5 . Raw data for FHV-infected hemocytes (Figure 4 and Figure S4 ). Supplemental Table S6 . Raw data for FHV-infected purple-eyed pupal cells ( Figure 5 and Figure S5 ). Supplemental Table S7 . Raw data for transfer of DWV infection from DWV-infected purple-eyed pupal cells to naïve purple-eyed pupal cell ( Figure 6 and Figure S6 ). Supplemental Table S8 . Raw data for transfer of FHV infection from FHV-infected purple-eyed pupal cells to naïve purple-eyed pupal cells ( Figure 6 and Figure S6 ). Supplemental Table S9 . Raw Ct values for immune gene expression in SBV-infected pupal cells (Figure 7 and Figure S7 ). Supplemental Table S10 . Raw data for immune gene expression in DWV-infected honey bee pupal cells (Figure 7 and Figure S8 ). Supplemental Table S11 . Raw data for immune gene expression in FHV-infected honey bee pupal cells (Figure 7 and Figure S9 ). Supplemental Table S12 . Raw data for immune gene expression in FHV-infected hemocytes ( Figure S10 ). Supplemental Table S13 . SBV fold change relative to 0 hpi in hemocytes. Supplemental Table S14 . SBV fold change relative to 0 hpi in pupal cells. Supplemental Table S15 . DWV fold change relative to 0 hpi in purple-eyed pupal cells. Supplemental Table S16 . FHV fold change relative to 0 hpi in hemocytes. Supplemental Table S17 . FHV fold change relative to 0 hpi in purple-eyed pupal cells. Supplemental Table S18 . DWV fold change relative to 0 hpi in naïve pupal cells treated with material from infected cells. Supplemental Table S19 . FHV fold change relative to 0 hpi in naïve pupal cells treated with material from infected cells. Supplemental Table S20 . Fold change and p-values for immune genes in SBV-infected pupae. Supplemental Table S21 . Immune gene fold change and p-values for DWV-infected honey bee pupal cells. Supplemental Table S22 . Immune gene fold change and p-values for FHV-infected honey bee pupal cells. Supplemental Table S23 . Immune gene fold change and p-values for FHV-infected hemocytes. Supplemental Table S24 . Virus testing in corresponding honey bee larval carcass and hemocyte samples indicate that hemocytes are natural sites of infection for black queen cell virus (BQCV). Supplemental Table S25 . Negative strand-specific RT-PCR confirms viral replication in hemocytes and pupal cells. Supplemental Figure S1 . Larval hemocyte cultures have relatively few contaminating adipocytes. Supplemental Figure S2 . Sacbrood virus (SBV) replicates in primary honey bee pupal cell cultures. Supplemental Figure S3 . Deformed wing virus (DWV) replicates in primary honey bee pupal cell cultures. Supplemental Figure S4 . Flock House virus (FHV) replicates in primary honey bee hemocytes. Supplemental Figure S5 . Flock House virus (FHV) replicates in primary honey bee pupal cells. Supplemental Figure S6 . DWV and FHV infection transferred from infected to naïve honey bee pupal cells. Supplemental Figure S7 . Infection of primary pupal cells with SBV results in higher bap-1 expression. Supplemental Figure S8 . Infection of primary honey bee pupal cells with DWV has modest impact on the expression of select immune genes. Supplemental Figure S9 . Infection of primary honey bee pupal cells with FHV results in differential regulation of immune genes. Supplemental Figure S10 . Infection of honey bee hemocytes with FHV results in differential regulation of immune genes. Supplemental Figure S11 . Sacbrood virus (SBV) inoculum was free of several other common honey bee infecting viruses. Supplemental Figure S12 . Deformed wing virus (DWV) inoculum was free of several other common honey bee infecting viruses. Institutional Review Board Statement: Ethical review and approval were waived for this study, since the study involved only the use of invertebrate animals (i.e., honey bees), and Biosafety Protocols and Standard Operating Procedures were approved by Montana State University's Biosafety Committee (Approval Date: June 2020; Protocol Number: 2020-5-19).

The majority of the data generated or analyzed during this study are included in this published article and its Supplementary Material files (available online). Additional data are available from the corresponding author upon request.

Identification of Viral Suppressors of RNAi by a Reporter Assay in Drosophila S2 Cell Culture

Drosophila Cell Lines as Model Systems and as an Experimental Tool

Human stem cell models to study host-virus interactions in the central nervous system

Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation

Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier

Technology: Enhancing the Culture of Diagnosing Human Diseases

Cell Lines for Honey Bee Virus Research

A Cell Line Resource Derived from Honey Bee (Apis mellifera) Embryonic Tissues

In vivo and in vitro infection dynamics of honey bee viruses

A national survey of managed honey bee 2010-11 winter colony losses in the USA: Results from the Bee Informed Partnership

A national survey of managed honey bee 2011-12 winter colony losses in the United States: Results from the Bee Informed Partnership

A national survey of managed honey bee 2012-2013 annual colony losses in the USA: Results from the Bee Informed Partnership

A national survey of managed honey bee 2014-2015 annual colony losses in the USA

A national survey of managed honey bee 2015-2016 annual colony losses in the USA

Multiyear survey targeting disease incidence in US honey bees

Honey Bee Colony Losses 2016-2017: Preliminary Results; Bee Informed Partnership

United States Honey Bee Colony Losses 2017-2018: Preliminary Results; Bee Informed Partnership

Honey Bee Colony Losses in the United States: Preliminary Results; Bee Informed Partnership

Bee declines driven by combined stress from parasites, pesticides, and lack of flowers

Pathogen webs in collapsing honey bee colonies

The buzz about honey bee viruses

Bee Viruses: Ecology, Pathogenicity, and Impacts

Recently identified bee viruses and their impact on bee pollinators

Characterization of two species of trypanosomatidae from the honey bee Apis mellifera: Crithidia mellificae langridge and mcghee, and lotmaria passim n. gen., n. sp

A draft genome of the honey bee trypanosomatid parasite crithidia mellificae

Differential diagnosis of the honey bee trypanosomatids Crithidia mellificae and Lotmaria passim

Genomic Analyses of the Microsporidian Nosema ceranae, an Emergent Pathogen of Honey Bees

American Foulbrood in honeybees and its causative agent, Paenibacillus larvae

European foulbrood in honey bees

Ecology of Varroa destructor, the Major Ectoparasite of the Western Honey Bee, Apis mellifera

Diversity and Global Distribution of Viruses of the Western Honey Bee, Apis mellifera

Metatranscriptome Analysis of Sympatric Bee Species Identifies Bee Virus Variants and a New Virus, Andrena-Associated Bee Virus-1. Viruses

Study of the Metatranscriptome of Eight Social and Solitary Wild Bee Species Reveals Novel Viruses and Bee Parasites

Genome Characterization, Prevalence and Distribution of a Macula-Like Virus from Apis mellifera and Varroa destructor

A Diverse Range of Novel RNA Viruses in Geographically Distinct Honey Bee Populations

Two novel viruses associated with the Apis mellifera pathogenic mite Varroa destructor

Presence of Apis Rhabdovirus-1 in Populations of Pollinators and Their Parasites from Two Continents

Investigating the viral ecology of global bee communities with high-throughput metagenomics

Temporal Analysis of the Honey Bee Microbiome Reveals Four Novel Viruses and Seasonal Prevalence of Known Viruses, Nosema, and Crithidia

Hymenoptera associated eukaryotic virome lacks host specificity

Analysis of the Complete Genome Sequence of Acute Bee Paralysis Virus Shows That It Belongs to the Novel Group of Insect-Infecting RNA Viruses

Analysis of the complete genome sequence of black queen-cell virus, a picorna-like virus of honey bees

Molecular characterisation and phylogenetic analysis of Chronic bee paralysis virus, a honey bee virus

Chronic bee paralysis: A disease and a virus like no other?

Molecular and biological characterization of deformed wing virus of honeybees (Apis mellifera L.)

Deformed wing virus

Isolation and characterization of Israeli acute paralysis virus, a dicistrovirus affecting honeybees in Israel: Evidence for diversity due to intra-and inter-species recombination

Complete nucleotide sequence of Kashmir bee virus and comparison with acute bee paralysis virus

The nucleotide sequence of sacbrood virus of the honey bee: An insect picorna-like virus

The discovery Halictivirus resolves the Sinaivirus phylogeny

Honey bee infecting Lake Sinai viruses

Patterns of viral infection in honey bee queens

Seasonal dynamics and co-occurrence patterns of honey bee pathogens revealed by high-throughput RT-qPCR analysis

The incidence and world distribution of honey bee viruses

World Distribution of Major Honeybee Diseases and Pests

The worldwide health status of honey bees

Honey bee viruses

The multiplication and spread of sacbrood virus of bees

Intricate transmission routes and interactions between picorna-like viruses (Kashmir bee virus and sacbrood virus) with the honeybee host and the parasitic varroa mite

The prevalence of viruses of honey bees in Britain

Prevalence and seasonal variations of six bee viruses in Apis mellifera L. and Varroa destructor mite populations in France

Longitudinal monitoring of honey bee colonies reveals dynamic nature of virus abundance and indicates a negative impact of Lake Sinai virus 2 on colony health

Pathogen prevalence and abundance in honey bee colonies involved in almond pollination

Green Bees: Reverse Genetic Analysis of Deformed Wing Virus Transmission, Replication, and Tropism

Deformed wing virus: Replication and viral load in mites (Varroa destructor)

Detection of Deformed wing virus, a honey bee viral pathogen, in bumble bees (Bombus terrestris and Bombus pascuorum) with wing deformities

Horizontal transmission of deformed wing virus: Pathological consequences in adult bees (Apis mellifera) depend on the transmission route

Covert deformed wing virus infections have long-term deleterious effects on honeybee foraging and survival

Dead or alive: Deformed wing virus and Varroa destructor reduce the life span of winter honeybees

Meta-analysis of honey bee neurogenomic response links Deformed wing virus type A to precocious behavioral maturation

Flight performance of actively foraging honey bees is reduced by a common pathogen

Novel Insect Picorna-Like Virus Identified in the Brains of Aggressive Worker Honeybees

Virus infection causes specific learning deficits in honeybee foragers

Transcriptomic Responses of the Honey Bee Brain to Infection with Deformed Wing Virus

Quantitative patterns of vertical transmission of deformed wing virus in honey bees

Vertical-transmission routes for deformed wing virus of honeybees (Apis mellifera)

Pupal cannibalism by worker honey bees contributes to the spread of deformed wing virus

Deformed wing virus and drone mating flights in the honey bee (Apis mellifera): Implications for sexual transmission of a major honey bee virus

Deformed wing virus can be transmitted during natural mating in honey bees and infect the queens

Venereal and vertical transmission of deformed wing virus in honeybees (Apis mellifera L.)

Bee Viruses: Routes of Infection in Hymenoptera

Varroa destructor feeds primarily on honey bee fat body tissue and not hemolymph

Varroa destructor mites vector and transmit pathogenic honey bee viruses acquired from an artificial diet

Direct Evidence for Infection of Varroa destructor Mites with the Bee-Pathogenic Deformed Wing Virus Variant B, but Not Variant A, via Fluorescence In Situ Hybridization Analysis

A Virulent Strain of Deformed Wing Virus (DWV) of Honeybees (Apis mellifera) Prevails after Varroa destructor-Mediated, or In Vitro

Deformed wing virus type A, a major honey bee pathogen, is vectored by the mite Varroa destructor in a non-propagative manner

Complete sequence of a picorna-like virus of the genus Iflavirus replicating in the mite Varroa destructor

Recombinants between Deformed wing virus and Varroa destructor virus-1 may prevail in Varroa destructor-infested honeybee colonies

Replication of Varroa destructor virus 1 (VDV-1) and a Varroa destructor virus 1-deformed wing virus recombinant (VDV-1-DWV) in the head of the honey bee

Diversity in a honey bee pathogen: First report of a third master variant of the Deformed Wing Virus quasispecies

Method Development and Application to Quantify the Role of Three DWV Master Variants in Overwinter Colony Losses of European Honey Bees

Evidence for positive selection and recombination hotspots in Deformed wing virus (DWV)

The German bee monitoring project: A long term study to understand periodically high winter losses of honey bee colonies

Synergistic parasite-pathogen interactions mediated by host immunity can drive the collapse of honeybee colonies

A mutualistic symbiosis between a parasitic mite and a pathogenic virus undermines honey bee immunity and health

Honey bee (Apis mellifera) colony health and pathogen composition in migratory beekeeping operations involved in California almond pollination

Disentangling multiple interactions in the hive ecosystem

Construction and Rescue of a Molecular Clone of Deformed Wing Virus (DWV)

The Iflaviruses Sacbrood virus and Deformed wing virus evoke different transcriptional responses in the honeybee which may facilitate their horizontal or vertical transmission

Parallel epigenomic and transcriptomic responses to viral infection in honey bees (Apis mellifera)

In vitro infection of pupae with Israeli acute paralysis virus suggests disturbance of transcriptional homeostasis in honey bees (Apis mellifera)

Honey Bee Viruses in Wild Bees: Viral Prevalence, Loads, and Experimental Inoculation

Preparation of Virus-Enriched Inoculum for Oral Infection of Honey Bees (Apis Mellifera)

Amitraz and its metabolite modulate honey bee cardiac function and tolerance to viral infection

ATP-sensitive inwardly rectifying potassium channel regulation of viral infections in honey bees

Virus and dsRNA-triggered transcriptional responses reveal key components of honey bee antiviral defense

Non-Specific dsRNA-Mediated Antiviral Response in the Honey Bee

The Heat Shock Response in the Western Honey Bee (Apis mellifera) is Antiviral

Flock house virus replicates and expresses green fluorescent protein in mosquitoes

Replication of flock house virus in three genera of medically important insects

RNA Interference Directs Innate Immunity Against Viruses in Adult Drosophila

The structure of the flock house virus B2 protein, a viral suppressor of RNA interference, shows a novel mode of double-stranded RNA recognition

Recent insights into the biology and biomedical applications of Flock House virus

Assembly-dependent maturation cleavage in provirions of a small icosahedral insect ribovirus

Synthesis of template-sense, single-strand Flockhouse virus RNA in a cell-free replication system

Flock house virus RNA polymerase is a transmembrane protein with amino-terminal sequences sufficient for mitochondrial localization and membrane insertion

Flock house virus RNA replicates on outer mitochondrial membranes in Drosophila cells

Characterization and template properties of RNA dimers generated during flock house virus RNA replication

Flock House virus subgenomic RNA3 is replicated and its replication correlates with transactivation of RNA2

A small RNA virus isolated from the grass grub, Costelytra zealandica (Coleoptera: Scarabaeidae)

Flock house virus: A Nodavirus isolated fromCostelytra zealandica (White) (Coleoptera: Scarabaeida)

The Interplay Between Viruses and RNAi Pathways in Insects

The long and short of antiviral defense: Small RNA-based immunity in insects

RNA interference-mediated antiviral defense in insects

Viral suppressors of RNA-based viral immunity: Host targets

Dual modes of RNA-silencing suppression by Flock House virus protein B2

Animal virus replication and RNAi-mediated antiviral silencing in Caenorhabditis elegans

Honey Bee and Bumble Bee Antiviral Defense. Viruses

Making connections in insect innate immunity

Insect antiviral innate immunity: Pathways, effectors, and connections

Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes

A genomewide screen for components of the RNAi pathway in Drosophila cultured cells

Essential function in vivo for Dicer-2 in host defense against RNA viruses in drosophila

The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster

RNAi is an antiviral immune response against a dsRNA virus in Drosophila melanogaster

Alphavirus-derived small RNAs modulate pathogenesis in disease vector mosquitoes

IAPV, a bee-affecting virus associated with Colony Collapse Disorder can be silenced by dsRNA ingestion

Characterization of viral siRNA populations in honey bee colony collapse disorder

The immune response of the small interfering RNA pathway in the defense against bee viruses

Meeus, I. The effect of oral administration of dsRNA on viral replication and mortality in Bombus terrestris

In vivo study of Dicer-2-mediated immune response of the small interfering RNA pathway upon systemic infections of virulent and avirulent viruses in Bombus terrestris

RNA interference in honeybees: Off-target effects caused by dsRNA

Non-Target Effects of Green Fluorescent Protein (GFP)-Derived Double-Stranded RNA (dsRNA-GFP) Used in Honey Bee RNA Interference (RNAi) Assays. Insects

Comparing Survival of Israeli Acute Paralysis Virus Infection among Stocks of U.S. Honey Bees. Insects

Unity in defence: Honeybee workers exhibit conserved molecular responses to diverse pathogens

Differential expression pattern of Vago in bumblebee (Bombus terrestris), induced by virulent and avirulent virus infections

Neonicotinoid clothianidin adversely affects insect immunity and promotes replication of a viral pathogen in honey bees

Reduction in deformed wing virus infection in larval and adult honey bees (Apis mellifera L.) by double-stranded RNA ingestion

Israeli Acute Paralysis Virus Infection Leads to an Enhanced RNA Interference Response and Not Its Suppression in the Bumblebee Bombus terrestris

Infection of a Lepidopteran Cell Line with Deformed Wing Virus

Standard methods for cell cultures in Apis mellifera research

Challenges associated with research on RNA viruses of insects

Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E

An agent in the Aedes aegypti cell line (Peleg) which causes fusion of Aedes albopictus cells

Proteomics informed by transcriptomics for characterising active transposable elements and genome annotation in Aedes aegypti

Virus discovery by deep sequencing and assembly of virus-derived small silencing RNAs

Novel Macula-Like Virus Identified in Bombyx mori Cultured Cells

Latent Infection of a New Alphanodavirus in an Insect Cell Line

Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines

Differential Susceptibilities of Human Lung Primary Cells to H1N1 Influenza Viruses

Bacterial Lipopolysaccharide Inhibits Dengue Virus Infection of Primary Human Monocytes/Macrophages by Blockade of Virus Entry via a CD14-Dependent Mechanism

Insect hemocytes and their role in immunity

Morphological and functional characterization of honey bee, Apis mellifera, hemocyte cell communities

Honey Bee Hemocyte Profiling by Flow Cytometry

Postembryonic Hematopoiesis in Drosophila

Hemolectin expression reveals functional heterogeneity in honey bee (Apis mellifera) hemocytes

Replication of sacbrood virus in larval and adult honeybees, Apis mellifera

Haemolymph removal by Varroa mite destabilizes the dynamical interaction between immune effectors and virus in bees, as predicted by Volterra's model

Circulating Immune Cells Mediate a Systemic RNAi-Based Adaptive Antiviral Response in Drosophila

Antiviral immunity in Drosophila requires systemic RNA interference spread

The honey bee gene, bee antiviral protein-1, formerly MF116383, is a taxonomically restricted antiviral immune gene

Using a Sugar Roll to Identify Populations of Varroa Destructor in Honey Bee Colonies

Tools for Varroa Management: A Guide to Effective Varroa Sampling and Control

Medium for development of bee cell cultures (Apis mellifera: Hymenoptera: Apidae)

Standard methods for virus research in Apis mellifera

Plaque assay for black beetle virus

Specific packaging of nodaviral RNA2 requires the N-terminus of the capsid protein

RT-PCR analysis of Deformed wing virus in honeybees (Apis mellifera) and mites (Varroa destructor)

Molecular approaches to the analysis of deformed wing virus replication and pathogenesis in the honey bee, Apis mellifera

Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream

A Multiple Comparison Procedure for Comparing Several Treatments with a Control

Constructing Confidence Sets Using Rank Statistics

Comparison of The Replication of Positive-Stranded Rna Viruses of Plants and Animals

Hemocytes are sites of enteric virus persistence within oysters

White spot syndrome virus (WSSV) infects specific hemocytes of the shrimp Penaeus merguiensis

Opportunistic intruders: How viruses orchestrate ER functions to infect cells

Breaking Bad: How Viruses Subvert the Cell Cycle

Analysis of the Contribution of Hemocytes and Autophagy to Drosophila Antiviral Immunity

Israeli Acute Paralysis Virus: Epidemiology, Pathogenesis and Implications for Honey Bee Health

Induction and Suppression of RNA Silencing by an Animal Virus

Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila

A Viral Protein Restricts Drosophila RNAi Immunity by Regulating Argonaute Activity and Stability

We are grateful to Marie Pizzorno for help with producing the DWV stock, Katie F. Daughenbaugh for discussions throughout the experiments, and Matthew Taylor for assistance with honey bee hemocyte imaging. We would also like to thank the members of Flenniken laboratory (Brian Ross and Naomi Kaku) for reviewing this manuscript prior to publication.

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.